$SNGX
BEARISH2026-04-28Price around the call
↓ 2026-04-28
By horizon✗ miss+161.3%
1d
✗ +1.9%
5d
✓ -6.1%
21d
✗ +161.3%
Original post
Monaco · 2026-04-28
$SNGX #fail Soligenix Announces Interim Results from the Phase 3 FLASH2 Trial Evaluating HyBryte™ in Treatment of Cutaneous T-Cell Lymphoma https://t.co/CntBCNJFfk
View on X ↗